<SEC-DOCUMENT>0001193125-26-111286-index.html : 20260317
<SEC-HEADER>0001193125-26-111286.hdr.sgml : 20260317
<ACCEPTANCE-DATETIME>20260317173740
ACCESSION NUMBER:		0001193125-26-111286
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20260314
FILED AS OF DATE:		20260317
DATE AS OF CHANGE:		20260317

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Patel Naimish
		CENTRAL INDEX KEY:			0002021679
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37923
		FILM NUMBER:		26763729

	MAIL ADDRESS:	
		STREET 1:		C/O CRISPR THERAPEUTICS
		STREET 2:		105 WEST FIRST STREET
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02127

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CRISPR Therapeutics AG
		CENTRAL INDEX KEY:			0001674416
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				473173478
		STATE OF INCORPORATION:			V8
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		BAARERSTRASSE 14
		CITY:			ZUG
		PROVINCE COUNTRY:   	V8
		BUSINESS PHONE:		6173154600

	MAIL ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		BAARERSTRASSE 14
		CITY:			ZUG
		PROVINCE COUNTRY:   	V8
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>ownership.xml
<DESCRIPTION>4
<TEXT>
Document 1 - file: ownership.html

Document 1 - RAW XML: ownership.xml

</DOCUMENT>
</SEC-DOCUMENT>